- bulk
Supplier Type
- Manufacturer
- Trader
- Reagent
- contract manufacturer
- custom synthesis
Supplier Region
- Hyderabad(33)
- Mumbai(41)
- Maharashtra(20)
- Karnataka(9)
- New Delhi(6)
- Gujarat(30)
- Andhra Pradesh(5)
- Delhi(12)
- Vadodara(12)
- Telangana(3)
- Bangalore(3)
- Ahmedabad(11)
- Pune(4)
- Uttar Pradesh(11)
- Kolkata(3)
- Haryana(3)
- Madhya Pradesh(3)
- Rajasthan(1)
- Nagpur(1)
Purity
- Salicylic Acid
- Rasagiline Mesylate Impurity C
- Pure
- Potassium content 15.5 - 17.5
- NLT 98%
- NLT 95%
- NLT 90%
- more than 95%
- more than 90%
- Mesalazine EP Impurity H
- Mathadone (M225865) impurity. Used in synthesis of methadone, antispasmodics and other pharmaceutica
- Magnesium content 8.49% to 8.84%
- lemon-lime grade (purity, 70%), a clear water-white ...
- Greater than 99%
- Dipropargyl r- amino indane
- Dapagliflozin Intermediate, Dapagliflozin Impurity
- Chemically Pure
- API Impurity / In-house working standard
- Acetylsalicylic Acid EP Impurity C
- ABOVE 99%
- 99.98%
- 99.95%
- 99.91%
- 99.9
- 99.86%
- 99.85%
- 99.83%
- 99.73%
- 99.60%
- 99.50%
- 99.5%
- 99.47%
- 99.42%
- 99.29%
- 99.23%
- 99.20%
- 99.2%
- 99.05%
- 99.00%
- 99.0% e.e. Min
- 99% Minimum
- > 99%
- 99%
- >99%
- 98+
- 98.85%
- 98.60%
- 98.5 to 101.5%
- 98.21%
- 98.12%
- 98.00%
- 98%+
- 98%
- >98%
- 98 %
- 97-99%
- 97.57%
- 97.00%
- >97%
- 97%
- 97 to 98
- 97 %
- 96.80%
- 96.40%
- 96.39%
- 96.00 % Min
- 96%
- 95.00%
- 95.00 % Min
- 95% min
- >95%
- 95%
- 94.84%
- 94.25%
- 94.00%
- 93-98%
- 93.0 % Min
- 93 %- 101%
- 92.55%
- >92%
- 90-95%
- 90%-95%
- >90%
- 90%
- 90 % Min.
- 90 % Above
- 68.0 % Min
- 65%
- 25 MG 50 MG 100 MG 250 MG EXTRA
- 100%
- (R)-N,N-di(prop-2-yn-1-yl)-2,3- dihydro-1
Package
- 2.5501e+00925 MG 50 MG 100 MG 250 MG EXTRA
- 0MG TO GRAM
- 0Customized pack size availaible
- 25mg
- 50mg
- 100mg
- 250mg
- 500mg
- 1000mg
- 1gm
- 1g
- 5g
- 10Gram
- 10g
- 25g
- 50g
- 100g
- 100gm
- 500g
- 500gm
- 1kg
- 5kg
- 10kg
- 25kg
- 50kg
- 100kg
- 500kg
- 1MT
- 1and gm
- 95NLT %
- 250250 mg.
-
Paroxetine Impurity 45
1396174-70-1
-
Piperidine, 3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-
72473-26-8
-
D-α-Tocopherol
59-02-9
-
4-Fluorobenzeneboronic acid
1765-93-1
-
Cyclopentanecarboxylic acid
3400-45-1
-
cis-3-Hexenyl phenylacetate
42436-07-7
-
CIS-3-HEXENYL OXY-ACETALDEHYDE
68133-72-2
-
CIS-3-HEXENYL ISOBUTYRATE
41519-23-7
-
4-Aminopyrazolo[3,4-d]pyrimidine
2380-63-4
-
((3AS,5R,6S,6aS)-6-hydroxy-2,2-dimethyltetrahydrofuro[2,3-d][1,3]dioxol-5-yl)(morpholino)methanone
1103738-19-7
Paroxetine Related Compound D/Paroxetine EP Impurity E/Cis-paroxetine 1396174-70-1
Vitamin E 59-02-9
4-Fluorophenylboronic acid 1765-93-1
Cis-3-Hexenyl phenylacetate 42436-07-7
4-Amino-1H-pyrazolo[3,4-d]pyrimidine 2380-63-4
(5S)-D-xylo-Pentodialdo-5,2-furanose, 4,5-O-(1-Methylethylidene)-1-C-4-Morpholinyl 1103738-19-7
D-Norpseudoephedrine 492-39-7
Montelukast acyl-b-D-glucuronide 188717-17-1
ALPHA-D-Glucose 492-62-6
(±)-Cis-1-Phenyl-2-(phthalimidomethyl)-N,N-diethylcyclopropanecarboxamide 105310-75-6